Who We Are

Probionic Corp., established in 2000, is a biotechnology company dedicated to the research and development of targeted probiotic strains for chronic and microbiome-related conditions. Founded as an independent venture under the Korea Research Institute of Bioscience and Biotechnology (KRIBB), the company has developed advanced expertise in microbial ecosystematics and microbiome science.

Today, Probionic develops and manufactures premium probiotic ingredients under GMP-certified standards, supplying B2B partners across nutraceutical, cosmeceutical, and veterinary industries worldwide.

Our Vision

Probionic aspires to be the front-runner in targeted-microbiome therapeutics and personalized medicine. We believe that our innovations can bring out the unlimited possibilities of probiotics and through this, we can deliver a better quality of life for people around the world.

Our mission

Research on the human microbiome has shed light on the influence of gut bacteria with many of our health conditions. Based on this belief, Probionic aims to create a revolution in the probiotic market and healthcare sector by developing next generation microbiome drugs as an active pharmaceutical and medicinal food ingredient as well as new bio-therapeutic solutions for chronic illnesses.

Our EXPERTISE

OUR CORE VALUES - 5P

Our ACTIVITIES